Skip to main content

Table 2 Clinical observations and ASMT activity in B lymphoblastoid cell line of patients with ID and ASMT mutations.

From: Mutation screening of ASMT, the last enzyme of the melatonin pathway, in a large sample of patients with Intellectual Disability

Individuals

Variants

ASMT activity (pmol/mg prot/30 min)

Clinical observations

Other known genetic anomalies

Patient D27

N13H

1.5

Mild ID. No other abnormalities or autistic features.

None

Patient P42

N17K

1.2

IQ:76, hyperkinesis, language delay, attention deficit and impulsivity, no epilepsy, no dysmorphic features.

ZNF41 mutation

Patient D33

V171M

1.6

Moderate ID, spasticity and severe language delay. No sleep-wake anomaly.

MECP2 duplication

Patient N6

IVS5+2T>C

0.9

Some autistic features; some compulsive behavior. Normal sleep pattern, although sleeps lightly and is easily wakened.

None

Patient P104

IVS7+1G>T

ND

Moderate ID, hyperactivity, attention deficit. No dysmorphic features. No evidence for sleeping problems or autistic features.

ARX duplication

Patient N79

E288D

0.9

Mild ID, epilepsy, dysmorphic features, scoliosis, strabismus, epilepsy, corpus callosum agenesis, subdural hygroma, hypermetry. Normal sleep pattern, although sleeps lightly. Some autistic features, with relatively low expressive communication and interpersonal relations, and compulsive behavior.

None

Patient T76

E288D

2.2

Severe ID, a few words. Dysmorphic features, hypotonia. Abnormal EEG, moderately enlarged lateral ventricles. No evidence for autistic features ('friendly behavior').

FG syndrome

Patient L45

L298F

1.7

Severe ID and no speech, however good social and eye contact. Never walked. No evidence for sleeping problems, or autistic features.

MCT8 mutation

Controls (n = 31) median (range)

WT

3.8 (0.2 - 9.5)